Clinical Trial Update: Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial updating pediatric use of Alacramyn in scorpion sting envenomation, with the study status showing as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scorpion Sting Envenomation

Drugs mentioned

• Alacramyn

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Scorpion Sting Envenomation | Phase 3 | Status: COMPLETED